Brief: Imricor Medical Systems Posts Total Revenue For Q3 Of US$270K, Down 13% On Q2
16/10/2024 01:41
Oct 16 (Reuters) - Imricor Medical Systems Inc IMR.AX :
* TOTAL REVENUE FOR Q3 OF US$270K DOWN 13% ON Q2
Source text for Eikon: ID:nASXbGtmpy
Further company coverage: IMR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion